Reactivation of ocular malignant melanoma after renal transplantation.
D000328:Adult; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D005134:Eye Neoplasms / Q000150:complications / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation; D008545:Melanoma / Q000150:complications / Q000209:etiology* / Q000276:immunology; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use; D011704:Pyelonephritis / Q000150:complications / Q000601:surgery; D014184:Transplantation, Homologous / Q000009:adverse effects*; D014603:Uveal Diseases / Q000150:complications / Q000209:etiology*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D001379:Azathioprine; D008775:Methylprednisolone